跳转至内容
Merck
CN

主要文件

查看所有文档

I1804

茚满

95%

别名:

二氢化茚

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:
C9H10
化学文摘社编号:
496-11-7
分子量:
118.18
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
24895949
EC Number:
207-814-7
Beilstein/REAXYS Number:
1904376
MDL number:
MFCD00003795
Assay:
95%
Form:
liquid
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Quality Level

100

assay

95%

form

liquid

refractive index

n20/D 1.537 (lit.)

bp

176 °C (lit.)

mp

−51 °C (lit.)

density

0.965 g/mL at 25 °C (lit.)

SMILES string

C1Cc2ccccc2C1

InChI

1S/C9H10/c1-2-5-9-7-3-6-8(9)4-1/h1-2,4-5H,3,6-7H2

InChI key

PQNFLJBBNBOBRQ-UHFFFAOYSA-N

Gene Information

human ... CYP1A2(1544)

Still not finding the right product?

Explore all of our products under 茚满

pictograms

FlameHealth hazard
GHS02,GHS08

signalword

Danger

hcodes

H226,H304

Hazard Classifications

Asp. Tox. 1 - Flam. Liq. 3

存储类别

3 - Flammable liquids

wgk

WGK 3

flash_point_f

129.2 °F - closed cup

flash_point_c

54 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

法规信息

危险化学品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
STBJ6192
STBH4583
STBG9280
STBF4864V
STBD5095V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Stuart N L Bennett et al.
Bioorganic & medicinal chemistry letters, 20(12), 3511-3514 (2010-05-25)
A series of carboxylic acid glycogen phosphorylase inhibitors, which have potential as oral antidiabetic agents, is described. Defining and applying simple physicochemical design criteria was used to assess the opportunity and to focus synthetic efforts on compounds with the greatest
Tong-Xin Liu et al.
Organic letters, 13(22), 6130-6133 (2011-10-29)
The addition of aluminum chloride to the manganese acetate-mediated radical reaction of [60]fullerene with 2-arylmalonates, 2-benzylmalonates, and 2-arylcyanoacetates can switch the reaction pathway and affords a variety of structurally novel and scarce [60]fullerene-fused tetrahydronaphthalene and indane derivatives. These products are
Michael F Gross et al.
Bioorganic & medicinal chemistry letters, 17(10), 2849-2853 (2007-03-14)
A collection of aryl sulfonamido indanes based on the lead compound 1 was synthesized and evaluated for Kv1.5 inhibitory activity. Kv1.5 inhibitors have the potential to be atrium-selective agents for treatment of atrial fibrillation. (1R,2R)-1 has an IC(50) of 0.033microM
查看所有相关文献

全球贸易项目编号

货号GTIN
I1804-100ML04061833848128
I1804-500ML04061838124180